Jonathan CohenJonathan Cohen
Jonathan Cohen

Jonathan Cohen

Board Advisor

About

I am a physician-researcher and head of clinical research at the Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center. I am a senior medical oncologist, specializing in melanoma and cancer immunotherapy and also a member of the gastro-intestinal medical oncology team. I have extensive experience employing cancer-immunotherapy including cellular therapies and handling their toxicities. I also head development and conduction of the clinical program for adoptive cell therapy in our Institute. As head of clinical research, I am expanding research at all phases with a specific emphasis on early phase studies. My goal is to make cutting edge treatments available for our patients while further establishing the Sharett Institute as a center of excellence attracting established pharmaceutical companies, local start-ups and serving as a location to test new technologies stemming from local research. I hold a PhD in neuroscience and lead a research group investigating various aspects of cancer immunology. A main research topic combines my passion for oncology and neuroscience looking into the immunological response in brain metastases. I am a faculty member at the Hebrew University of Jerusalem and am involved in many formal and informal teaching activities.
Comments

No comments yet. Be the first to share your take.

Frequently asked

Who is Jonathan Cohen?

I am a physician-researcher and head of clinical research at the Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center. I am a senior medical oncologist, specializing in melanoma and cancer immunotherapy and also a member of the gastro-intestinal medical oncology team. I have extensive experience employing cancer-immunotherapy including cellular therapies and handling their toxi…

What is Jonathan Cohen's current role?

Jonathan Cohen is currently Board Advisor.

Profile

About Jonathan Cohen

Jonathan Cohen is Board Advisor. Jonathan is a board member of Pepticom. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.

Board member of